Noile-Immune Biotech, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -100.00% vs -19.23% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 36.14% vs 29.39% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "2.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-202.00",
          "val2": "-241.60",
          "chgp": "16.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-153.40",
          "val2": "-240.20",
          "chgp": "36.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-112,772.60%",
          "chgp": "11,277.26%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -34.21% vs -97.60% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 17.73% vs 14.65% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.00",
          "val2": "7.60",
          "chgp": "-34.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-797.30",
          "val2": "-1,069.20",
          "chgp": "25.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-793.50",
          "val2": "-964.50",
          "chgp": "17.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-159,450.80%",
          "val2": "-140,922.90%",
          "chgp": "-1,852.79%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

0.00

2.10

-100.00%

Operating Profit (PBDIT) excl Other Income

-202.00

-241.60

16.39%

Interest

0.00

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

-153.40

-240.20

36.14%

Operating Profit Margin (Excl OI)

0.00%

-112,772.60%

11,277.26%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -100.00% vs -19.23% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 36.14% vs 29.39% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

5.00

7.60

-34.21%

Operating Profit (PBDIT) excl Other Income

-797.30

-1,069.20

25.43%

Interest

0.00

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

-793.50

-964.50

17.73%

Operating Profit Margin (Excl OI)

-159,450.80%

-140,922.90%

-1,852.79%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -34.21% vs -97.60% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 17.73% vs 14.65% in Dec 2024

All Annual Results